If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
NEUROLOGY
ISSN 2054-4529 Vol 4.1 • July 2016 • emjreviews.com
INSIDE
Review of
EAN 2016
Copenhagen, Denmark
CONTENTS
EDITORIAL BOARD......................................................................................................................................... 4
CONGRESS REVIEW........................................................................................................................................ 12
• Review of the 2nd Congress of the European Academy of Neurology (EAN),
held in Copenhagen, Denmark, 28th-31st May 2016
INTERVIEWS WITH EMJ NEUROLOGY EDITORIAL BOARD................................................................. 28
SYMPOSIUM REVIEW
• BRAIN HEALTH: TRANSLATING SCIENTIFIC EVIDENCE INTO CLINICAL PRACTICE IN
NEUROLOGY ISSN 2054-4529
CONTENTS EDITORIAL BOARD.......................
NEUROLOGY • DEVELOPMENT AND TRANSLATION OF THER
Editorial Board Editor-in-Chief: Prof László V
Neurology Prof Nils Erik Gilhus, Professor of
SUBSCRIBE TOTHEEMJ NEWSLETTER NwEwwW.newSs.eLmjEr
Welcome Welcome to EMJ Neurology, an edition fi
SUBSCRIBE Follow us: FREE TO OUR YOUTUBE CHA
Foreword
MIGRAINE: THE SEVENTH DISABLER Frovatriptan i
EFFICACY IN THE TREATMENT OF MIGRAINE Migraine w
12 NEUROLOGY • July 2016
NEUROLOGY • July 2016
14 NEUROLOGY • July 2016
Congress Highlights Cultivating a Ne
Making the correct decision when treating a
Indeed, with 60 countries and territories re
we will need medical, ethical, and legal gu
Experts unveiled a five-phase framework at th
disease, designed to standardise clinical
Prehistoric finds show that skulls were being trep
The findings determined that low levels of f
Advances in migraine prevention give hope that we
Impairment to Sexuality Underestimated in Neurolo
Previous studies have suggested that the str
Dr Cláudia Borbinha, Department o
Praise for Scandinavian Research at European Neur
Valery L. Feigin Professor of Epidemiology and N
>200 investigators from 61 countries involved in
already suffering from these disorders. However,
in theory this should allow for the development o
strains on our society. Another impressive change
other on the ‘Brain and Mind in Ancient Greek Med
populations, another unique feature of the resear
Q: Have you had any mentors during your career th
BRAIN HEALTH: TRANSLATING SCIENTIFIC EVIDENCE I
Brain Volume Loss in Multiple Sclerosis:
could eventually lead to neuronal dysfunctio
treatments and may be more apparent in white matt
However, measurements of brain volume (whole brai
opportunity to enter extension studies.50-52 In C
QUESTION AND ANSWER SESSION Prof Sørensen note
Annu Rev Neurosci. 2008;31:247-69. 16. Sorbara CD
with Alemtuzumab: CARE-MS II. DX02. Presented at
EMJ EUROPEAN MEDICAL
Abstract Reviews FROM CHEMOTHERAPY TO TARGETED
EAN 2016 with cryptogenic stroke <55 years of ag
Abstract Reviews Cohen–Mansfield Agitation
EAN 2016 THE IMPACT OF BILINGU
Abstract Reviews REFERENCES 1. Bak TH. The neuro
EAN 2016 specifically highlight the Yale-Global T
Abstract Reviews blown Tourette’s syndrome’),
EAN 2016 (antipsychotics) are the most effective
Abstract Reviews syndrome and other tic disorder
If you are interested in submitting a paper to
EDITORS PICK The s
other neuropsychiatric illnesses, such as depress
CHALLENGES IN DIAGNOSIS There are many overlappi
Apathy 51% Depression 26% Pure apath 29% y
closer than those between apathy and depression;
Correspondingly, reward circuits and dopamine
Associations with other neuropsychiatric conditio
and Depression: Separate Factors in Parkinson
DEVELOPMENT AND TRANSLATION OF THERAPIES FOR
most common type of SMA.11 Disease onset occurs b
degradation by the proteasome.34 The proteasome h
Table 1: Current overview of clinical trials for
Table 1 continued. Trial number Study Sta
While the first-generation of SMN-dependen
FUTURE DEVELOPMENT AND CONCLUDING REMARKS At pr
8. Hamilton G, Gillingwater TH. Spinal muscular
Defects in Intestine in Severe Spinal Muscul
exon of human Survival Motor Neuron is regulated
WILSON’S DISEASE: AN INHERITED, SILENT,
A
Figure 1 continued. functionally disrupted.22 Du
supported by a trial in which clinical and geneti
In most Wilson’s disease patients presenting
A Clinical symptoms
However, LA-ICP-MS imaging studies ha
facilitate the otherwise cumbersome diagnosti
foods, and to treat any damage of the liver and t
accumulation and late-onset hepatic nodular
MULTIPLE SCLEROSIS: WHERE DO WE GO FROM HERE?
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS MS can be
without relapses, known as primary progressi
triggered by an infectious agent and evolve into
Table 1: Aetiopathology of multiple sclerosis. En
Clinical The cornerstone of the MS diagnosis
most important CSF test finding, and is a red flag
Table 2 continued. Biomarkers Source MS fi
regardless of disease activity. An incr
miR-23a, and miR-15b are decreased in PPMS and ar
social aspects in a clinical cohort. J Neur
73. Miller DH et al. Role of magnetic resonance
WHOLE SPECTRUM OF NATURAL PROGRESSION OF HAEM
which were highly suggestive of HB. A screening u
Figure 3: Gross specimen of the
therefore justified with en bloc removal of
REFERENCES 1. Chu LZ et al. Multifocal central n
ADVANCES IN THE MANAGEMENT OF TRANSIENT
TIA by a stroke specialist, its use is supported
or tenecteplase) and/or endovascular procedures.3
of treatment in most patients with cryptoge
The timing and amount of mobilisat
and minor ischemic stroke From noncerebro
new clinical construct. Lancet Neurol. 2014;1
EUROPEAN MEDICAL JOURNAL provides influential arti
Buyer’s Guide • ABBVIE, INC. • ACTELION PHAR
SUBSCRIBE TO RECEIVE THE LATEST PUBLICATIONS, NE